This report concludes that the value of the cystic fibrosis (CF) carrier test is the information it provides. No one can estimate in common terms what it means to an individual to possess information about his or her genetic status, especially when the value concerns reproductive decision-making. As our knowledge of the human genome increases, what we do with information such as CF carrier status will depend on the perceptions and beliefs of all Americans.

The report concludes that these technologies have the potential to provide new solutions to many agricultural problems. The challenge, however, will be whether government, industry, and the public can strike the proper balance of direction, oversight, and use to allow these technologies to flourish. Congress will be faced with many issues and choices as American agriculture moves into this new era.

This report analyzes the available information about special care units for people with dementia. It discusses ways in which the Federal Government could encourage and support what is positive about special care units and at the same time protect vulnerable patients and their families from special care units that actually provide nothing special for their residents.

This report is an extension of volume one, that discusses the standards for body-armor. The report describes the origin of the standard, the rationale for particular provisions, and the main points of controversy, which concern acceptable risks, the validity and discrimination of the test, and the reproducibility of results.

This report discusses the standards for body-armor. The report describes the origin of the standard, the rationale for particular provisions, and the main points of controversy, which concern acceptable risks, the validity and discrimination of the test, and the reproducibility of results.